OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41 | +2.5% | 10,780 | -9.8% | 0.00% | – |
| Q2 2023 | $40 | -99.9% | 11,955 | +45.5% | 0.00% | – |
| Q3 2021 | $28,000 | -79.6% | 8,218 | -76.7% | 0.00% | – |
| Q2 2021 | $137,000 | -14.9% | 35,227 | -12.1% | 0.00% | – |
| Q1 2021 | $161,000 | +360.0% | 40,077 | +160.9% | 0.00% | – |
| Q4 2020 | $35,000 | -76.2% | 15,359 | -40.1% | 0.00% | – |
| Q3 2020 | $147,000 | -15.0% | 25,635 | +8.7% | 0.00% | – |
| Q2 2020 | $173,000 | – | 23,574 | +8729.2% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 267 | -92.8% | 0.00% | – |
| Q1 2019 | $7,000 | -75.0% | 3,723 | -24.6% | 0.00% | – |
| Q3 2018 | $28,000 | +154.5% | 4,938 | +247.7% | 0.00% | – |
| Q2 2018 | $11,000 | -38.9% | 1,420 | -44.1% | 0.00% | – |
| Q1 2018 | $18,000 | +125.0% | 2,538 | +216.9% | 0.00% | – |
| Q4 2017 | $8,000 | +700.0% | 801 | +578.8% | 0.00% | – |
| Q3 2017 | $1,000 | – | 118 | +2850.0% | 0.00% | – |
| Q2 2017 | $0 | – | 4 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 1,319,679 | $4,329 | 18.57% |
| Madison Avenue Partners, LP | 3,307,605 | $10,848,943 | 2.37% |
| CHI Advisors LLC | 864,822 | $2,836,616 | 0.86% |
| Rubric Capital Management LP | 5,445,910 | $17,862,585 | 0.76% |
| BVF INC/IL | 6,851,051 | $22,471,447 | 0.63% |
| EcoR1 Capital, LLC | 6,117,400 | $20,065,072 | 0.49% |
| Artal Group S.A. | 2,500,000 | $8,200 | 0.25% |
| Tejara Capital Ltd | 112,591 | $369,298 | 0.18% |
| DCF Advisers, LLC | 64,764 | $212,426 | 0.11% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 801,152 | $2,627,779 | 0.06% |